| 摘要 |
The invention provides an in vitro method for predicting whether a patient would be responsive to a treatment with a TNFa blocking agent, which method comprises determining the expression level of eight genes in a biological sample of said patient, wherein said genes are EPS15, HLA-DPB1, AKAP9, RASGRP3, MTCBP-1, PTNP12, MRPL22 and RPS28. The invention further provides a DNA chip for performing such method. |
| 申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);SABLIER, JEAN-PHILIPPE;DAVEAU, MARYVONNE;GAUTHIER-JAUNEAU, ANNE-CHRISTINE;VITTECOQ, OLIVIER;LE LOET, XAVIER;DARAGON, ALAIN;MEJJAD, OTHMANE;LEQUERRE, THIERRY |
发明人 |
SABLIER, JEAN-PHILIPPE;DAVEAU, MARYVONNE;GAUTHIER-JAUNEAU, ANNE-CHRISTINE;VITTECOQ, OLIVIER;LE LOET, XAVIER;DARAGON, ALAIN;MEJJAD, OTHMANE;LEQUERRE, THIERRY |
